E-cigarettes are devices designed to deliver nicotine to users without burning tobacco. These are being marketed globally as a healthier substitute to the conventional cigarettes and as smoking quitting aids. The use of these devices has increased recently in developed countries with approximately 1.3 million users reported in the United Kingdom in 2013. Perception of these products as a safe alternative, appealing advertisements, and lax regulatory policies have helped gain popularity among the public. Despite all these claims, a debate is on-going because of insufficient scientific data regarding safety and efficacy of e-cigarettes as well as awareness of the potential health hazards. To solve the dilemma, more scientific studies in this field are required. Prompt regulatory response with strict vigilance on marketing and advertising may be desirable in the interest of users and public at large.
World Health Organization Tobacco Free Initiative. Electronic cigarettes (e-cigarettes) or electronic nicotine delivery systems statement: WHO, Geneva. 2014. Available at URL: http://www.who.int/tobacco/communications/statements/eletronic_cigarettes/en/index.html. Accessed June 2014.
Trtchounian A, Willams M, Talbot P. Conventional and electronic cigarettes (e-cigarettes) have different smoking properties. Nicotine Tob Res 2010;12:905-12.
Williams, M, Talbot P. Variability among electronic cigarettes in the pressure drop, airflow rate, and aerosol production. Nicotine Tob Res 2011;13:1276-83.
Adkison SE, O'Connor RJ, Bansal-Travers M, Hyland A, Borland R, Yong HH, et al. Electronic nicotine delivery systems: international tobacco control four country survey. Am J Prev Med 2013;44:207-15.
Medicines and Healthcare Products Regulatory Agency. Nicotine containing products. London, UK: MHRA, 2013. Available at URL: http://www.mhra.gov.uk/Safetyinformation/General safety information and advice/Product specific information and advice/Product specific information andadvice%E2%80%93M%E2%80%93T/Nicotine Containing Products/index.htm. Accessed November 2013.
Zhu SH, Gamst A, Lee M, Cummins S, Yin L, Zoref L. The use and perception of electronic cigarettes and snus among the U.S. population. PLoS One 2013;8:e79332.
Dockrell M, Morrison R, Bauld L, McNeill A. E-cigarettes: prevalence and attitudes in Great Britain. Nicotine Tob Res 2013;15:1737-44.
Goniewicz ML, Lingas EO, Hajek P. Patterns of electronic cigarette use and user beliefs about their safety and benefits: an internet survey. Drug Alcohol Rev 2013;32:133-40.
Centers for Disease Control and Prevention. Notes from the field: electronic cigarette use among middle and high school students—United States, 2011–2012. Morb Mortal Wkly Rep 2013;62:729-30.
Lee S, Grana RA, Glantz SA. Electronic-cigarette use among Korean adolescents: a cross-sectional study of market penetration, dual use, and relationship to quit attempts and former smoking. J Adolesc Health 2014;54:684-90.
Goniewicz ML, Zielinska-Danch W. Electronic cigarette use among teenagers and young adults in Poland. Pediatrics 2012;130:e879-e885.
Grana R, Benowitz N, Stanton AG. E-Cigarettes: a scientific review. Circulation 2014;129:1972-86.
Sciencelab.com, Inc. Material Data Safety Sheet: Propylene Glycol. Updated May 21, 2013. Sciencelab.com, Inc., Houston, TX.
Cobb NK, Byron MJ, Abrams DB, Shields PG. Novel nicotine delivery systems and public health: the rise of the ‘e-cigarette’. Am J Public Health 2010;100:2340-42.
Behar RZ, Davis B, Wang Y, Bahl V, Lin S, Talbot P. Identification of toxicants in cinnamon-flavored electronic cigarette refill fluids. Toxicology in Vitro 2014;28:198-208.
Bahl V, Lin S, Xu N, Davis B, Wang YH, Talbot P. Comparison of electronic cigarette refill fluid cytotoxicity using embryonic and adult models. Reprod Toxicol 2012;34:529-37.
Zhang Y, Sumner W, Chen DR. In vitro particle size distributions in electronic and conventional cigarette aerosols suggest comparable deposition patterns. Nicotine Tob Res 2013;15:501-8.
Williams M, Villarreal A, Bozhilov K, Lin S, Talbot P. Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. PLoS One 2013;8:e57987.
Richardson A, Ganz O, Stalgaitis C, Abrams D, Vallone D. Noncombustible tobacco product advertising: how companies are selling the new face of tobacco. Nicotine Tob Res 2014;16:606-14.
De Andrade M, Hastings G, Angus K, Dixon D, Purves R. The marketing of electronic cigarettes in the UK. Cancer Research (UK) 2013.
Grana RA, Ling PM. Smoking revolution? A content analysis of electronic cigarette retail websites. Am J Prev Med 2014;46:395-403.
Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet 2013;382:1629-37.
Caponnetto P, Campagna D, Cibella F, Morjaria JB, Caruso M, Russo C, et al. Efficiency and safety of an electronic cigarette (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One 2013;8:e66317.
Torjesen I. E-cigarettes are to be regulated as medicines from 2016. Br Med J 2013;346:f3859.
Bam TS, Berezhnova I, Jones A, Latif E, Quan G. Position statement on electronic cigarettes or electronic nicotine delivery systems. Int J Tuberc Lung Dis 2014;18:5-7.